| 7001 | DUSP29 levels | GCST90469052 | 0.36 |
| 7002 | SIGLEC8 levels | GCST90089886 | 0.36 |
| 7003 | Bone density Z-score | GCST90278621 | 0.36 |
| 7004 | BSG/TNFRSF4 ratio | GCST90313536 | 0.36 |
| 7005 | SOD1 levels | GCST90470704 | 0.36 |
| 7006 | CD84/CDKN1A ratio | GCST90313909 | 0.36 |
| 7007 | C9 Carnitine levels in chronic kidney disease | GCST90257682 | 0.36 |
| 7008 | CD300C/GOLM2 ratio | GCST90313788 | 0.36 |
| 7009 | LPO levels | GCST90241730 | 0.36 |
| 7010 | FHIT/PMVK ratio | GCST90314822 | 0.36 |
| 7011 | Processed meat intake | Diet | UKBB00000711 | 0.35 |
| 7012 | CHCHD10 levels | GCST90468738 | 0.35 |
| 7013 | CDC26 levels | GCST90468663 | 0.35 |
| 7014 | Central serous chorioretinopathy | GCST90268400 | 0.35 |
| 7015 | Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4) | GCST90475984 | 0.35 |
| 7016 | Basophil count variance | GCST90565682 | 0.35 |
| 7017 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478 | ECGA000478 | 0.35 |
| 7018 | ITGAL levels | GCST90469637 | 0.35 |
| 7019 | AXIN1/HEXIM1 ratio | GCST90313408 | 0.35 |
| 7020 | PCYT2 levels | GCST90470178 | 0.35 |
| 7021 | SERPINF2 levels | GCST90470599 | 0.35 |
| 7022 | IDP T1 SIENAX grey normalised volume | GCST90002430 | 0.35 |
| 7023 | ADAMTS15/SULT2A1 ratio | GCST90313171 | 0.35 |
| 7024 | Concentration of LDL particles (UKB data field 23429) | GCST90269526 | 0.35 |
| 7025 | Polycythemia, secondary (PheCode 289.8) | GCST90475822 | 0.35 |
| 7026 | CSTB levels | GCST90179272 | 0.35 |
| 7027 | Retinal arteriolar tortuosity | GCST90270397 | 0.35 |
| 7028 | Omega-3 fatty acid levels | GCST90502056 | 0.35 |
| 7029 | MPHOSPH8 levels | GCST90469934 | 0.35 |
| 7030 | Neuroticism score | Mental health | UKBB00000496 | 0.35 |
| 7031 | Cholelithiasis and cholecystitis | digestive | UKBB00000133 | 0.35 |
| 7032 | Biological Sibling: Coronary Artery / Coronary Heart Disease | GCST90476370 | 0.35 |
| 7033 | Witnessed sudden violent death | Traumatic events | UKBB00000917 | 0.35 |
| 7034 | LONP1 levels | GCST90469785 | 0.35 |
| 7035 | Macular pucker | FING00000745 | 0.34 |
| 7036 | Type 2 diabetes | GCST90086072 | 0.34 |
| 7037 | GBP4 levels | GCST90469313 | 0.34 |
| 7038 | Migraine without aura | FING00000821 | 0.34 |
| 7039 | Continuous positive airway pressure | FING00000349 | 0.34 |
| 7040 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502592 | 0.34 |
| 7041 | ITGB5 levels | GCST90469645 | 0.34 |
| 7042 | SERPINB6 levels | GCST90470591 | 0.34 |
| 7043 | ICD10 E28.2: Polycystic ovarian syndrome | GCST90454205 | 0.34 |
| 7044 | Otosclerosis | FING00001131 | 0.34 |
| 7045 | hematocrit (maximum, inv-norm transformed) | GCST90475338 | 0.34 |
| 7046 | Concentration of VLDL particles | GCST90500246 | 0.34 |
| 7047 | ESAM/SCARF1 ratio | GCST90314715 | 0.34 |
| 7048 | IL15/IL18BP ratio | GCST90315148 | 0.34 |
| 7049 | F-cheese liking (derived food-liking factor) | GCST90094729 | 0.34 |
| 7050 | SAP18 levels | GCST90241432 | 0.34 |
| 7051 | CNTN3 levels | GCST90468805 | 0.34 |
| 7052 | Aspartate aminotransferase (AST, minimum, inv-norm transformed) | GCST90475124 | 0.34 |
| 7053 | Neutrophil count | GCST90002352 | 0.34 |
| 7054 | HippSubfield lh volume hippocampal-fissure | GCST90002672 | 0.34 |
| 7055 | ICAM3 levels | GCST90469500 | 0.34 |
| 7056 | IDS/SMPDL3A ratio | GCST90315126 | 0.34 |
| 7057 | Volume of right cortico-amygdaloid transition area | GCST90474911 | 0.34 |
| 7058 | Bicarbonate (mean, inv-norm transformed) | GCST90475148 | 0.34 |
| 7059 | C2/LILRB4 ratio | GCST90313554 | 0.34 |
| 7060 | BMP6 levels | GCST90468454 | 0.34 |
| 7061 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501075 | 0.34 |
| 7062 | F-fatty/dairy food liking (derived food-liking factor) | GCST90094760 | 0.34 |
| 7063 | HARS1 levels | GCST90469430 | 0.33 |
| 7064 | Chest pain or discomfort | Chest pain | UKBB00000128 | 0.33 |
| 7065 | Concentration of medium VLDL particles (UKB data field 23502) | GCST90269599 | 0.33 |
| 7066 | KITLG levels | GCST90428432 | 0.33 |
| 7067 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 0.33 |
| 7068 | Other diseases of liver | FING00001004 | 0.33 |
| 7069 | IGSF21 levels | GCST90469538 | 0.33 |
| 7070 | NT5C3A/SCRN1 ratio | GCST90315569 | 0.33 |
| 7071 | FSTL1 levels | GCST90469271 | 0.33 |
| 7072 | Total lipid levels in medium LDL | GCST90092910 | 0.33 |
| 7073 | SMOC1 levels | GCST90470682 | 0.33 |
| 7074 | Glycoprotein acetyls levels | GCST90497320 | 0.33 |
| 7075 | DTI TBSS L1 External capsule L | GCST90384461 | 0.33 |
| 7076 | Treatment/medication code - bendroflumethiazide | Medications | UKBB00000843 | 0.33 |
| 7077 | YTHDF3 levels | GCST90471091 | 0.33 |
| 7078 | Sleep apnoea | FING00001309 | 0.33 |
| 7079 | CELA3A/CTRC ratio | GCST90314012 | 0.33 |
| 7080 | FAM171B levels | GCST90090339 | 0.33 |
| 7081 | ERBB4 levels | GCST90469141 | 0.33 |
| 7082 | Symptoms concerning nutrition, metabolism, and development (PheCode 1002) | GCST90475556 | 0.33 |
| 7083 | SHMT1 levels | GCST90470627 | 0.33 |
| 7084 | PSME2 levels | GCST90470361 | 0.33 |
| 7085 | CASP3/SNAP23 ratio | GCST90313644 | 0.33 |
| 7086 | Active to sedentary transition probability | GCST90061429 | 0.33 |
| 7087 | CALB1 levels | GCST90468526 | 0.33 |
| 7088 | T1 FreeSurfer a2009s lh G front sup thickness | GCST90384757 | 0.33 |
| 7089 | Glycoprotein acetyls levels | GCST90092821 | 0.33 |
| 7090 | CD79B/CKAP4 ratio | GCST90313898 | 0.33 |
| 7091 | Cirrhosis | GCST90018606 | 0.32 |
| 7092 | Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302722 | 0.32 |
| 7093 | Hypertension | GCST90086092 | 0.32 |
| 7094 | Free cholesterol in medium HDL (UKB data field 23570) | GCST90269667 | 0.32 |
| 7095 | CCL4 levels | GCST90274770 | 0.32 |
| 7096 | LAT2 levels | GCST90469739 | 0.32 |
| 7097 | MPIG6B levels | GCST90469935 | 0.32 |
| 7098 | ELAC1 levels | GCST90469101 | 0.32 |
| 7099 | Cholesteryl esters in large LDL (UKB data field 23534) | GCST90269631 | 0.32 |
| 7100 | KLK6/MOG ratio | GCST90315255 | 0.32 |
| 7101 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488 | ECGA000488 | 0.32 |
| 7102 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 0.32 |
| 7103 | Phospholipid levels in small VLDL | GCST90092976 | 0.32 |
| 7104 | Cancer | GCST90086052 | 0.32 |
| 7105 | Chronic lymphocytic leukemia | GCST90624738 | 0.32 |
| 7106 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 0.32 |
| 7107 | Cholesteryl esters in LDL (UKB data field 23417) | GCST90269514 | 0.32 |
| 7108 | FKBP1B levels | GCST90469242 | 0.32 |
| 7109 | Physical activity (Total log acceleration 8pm-10pm) | GCST90061419 | 0.32 |
| 7110 | MAP2 levels | GCST90469853 | 0.32 |
| 7111 | REST UKBBICA NET100 1111 | GCST90386965 | 0.32 |
| 7112 | Cholesterol esters in very large HDL | GCST90500354 | 0.32 |
| 7113 | CRKL/MGLL ratio | GCST90314270 | 0.32 |
| 7114 | MCEMP1 levels | GCST90469872 | 0.32 |
| 7115 | Type 2 diabetes | GCST90018706 | 0.32 |
| 7116 | Takes medication for Macular Degeneration? | GCST90475387 | 0.32 |
| 7117 | X-17357 levels | GCST90200550 | 0.32 |
| 7118 | KLK8 levels | GCST90425492 | 0.32 |
| 7119 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 0.32 |
| 7120 | IPCEF1/SMAD1 ratio | GCST90315185 | 0.32 |
| 7121 | Loneliness (standard GWA) | GCST90267288 | 0.32 |
| 7122 | Colorectal cancer | GCST90018588 | 0.32 |
| 7123 | GNE levels | GCST90469370 | 0.32 |
| 7124 | GGACT levels | GCST90469333 | 0.32 |
| 7125 | Saturated fatty acids to total fatty acids percentage (UKB data field 23455) | GCST90269552 | 0.32 |
| 7126 | rfMRI connectivity (ICA100 edge 380) | GCST90005233 | 0.31 |
| 7127 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T455 | ECGU000455 | 0.31 |
| 7128 | Idiopathic pulmonary fibrosis | FING00000659 | 0.31 |
| 7129 | HS6ST2 levels | GCST90469480 | 0.31 |
| 7130 | Total cholines levels | GCST90092812 | 0.31 |
| 7131 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 0.31 |
| 7132 | ANXA4/HSPB1 ratio | GCST90313292 | 0.31 |
| 7133 | Propionylglycine levels | GCST90199705 | 0.31 |
| 7134 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 0.31 |
| 7135 | CXCL5 levels | GCST90468932 | 0.31 |
| 7136 | ENO2/SULT1A1 ratio | GCST90314669 | 0.31 |
| 7137 | PCBP2 levels | GCST90470167 | 0.31 |
| 7138 | GPD1 levels | GCST90469388 | 0.31 |
| 7139 | PTPRR levels | GCST90470386 | 0.31 |
| 7140 | aseg rh intensity Pallidum | GCST90003785 | 0.31 |
| 7141 | CAG-269 sp001915995 abundance in stool | GCST90032266 | 0.31 |
| 7142 | TNFRSF10B levels | GCST90470900 | 0.31 |
| 7143 | Average diameter for LDL particles (UKB data field 23432) | GCST90269529 | 0.31 |
| 7144 | DTI TBSS L3 Posterior corona radiata R | GCST90384550 | 0.31 |
| 7145 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476365 | 0.31 |
| 7146 | MANF levels | GCST90469846 | 0.31 |
| 7147 | IDP SWI T2star left caudate | GCST90003865 | 0.31 |
| 7148 | IL2RA levels | GCST90469585 | 0.30 |
| 7149 | Basophil count | GCST90002293 | 0.30 |
| 7150 | Concentration of medium VLDL particles | GCST90499016 | 0.30 |
| 7151 | Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccine | GCST90448695 | 0.30 |
| 7152 | HPCAL1/MPIG6B ratio | GCST90315073 | 0.30 |
| 7153 | OLR1 levels | GCST90470122 | 0.30 |
| 7154 | Cholesteryl esters in medium LDL (UKB data field 23541) | GCST90269638 | 0.30 |
| 7155 | Ever taken cannabis | Cannabis use | UKBB00000224 | 0.30 |
| 7156 | CNP levels | GCST90468798 | 0.30 |
| 7157 | 3-methyl-2-oxovalerate levels | GCST90243485 | 0.30 |
| 7158 | PSME1 levels | GCST90470360 | 0.30 |
| 7159 | MED18/SH2B3 ratio | GCST90315412 | 0.30 |
| 7160 | Omega-6 fatty acid levels | GCST90502514 | 0.30 |
| 7161 | Lymphoid neoplasms (B-cell phenocluster) | GCST90624736 | 0.30 |
| 7162 | CEP112 levels | GCST90468708 | 0.30 |
| 7163 | AAMDC levels | GCST90468186 | 0.30 |
| 7164 | IDP T1 FIRST right caudate volume | GCST90002439 | 0.30 |
| 7165 | ACRBP levels | GCST90468205 | 0.30 |
| 7166 | Physical activity (Total log acceleration 6am-8am) | GCST90061412 | 0.30 |
| 7167 | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | GCST90003972 | 0.30 |
| 7168 | MMP9/OLR1 ratio | GCST90315467 | 0.30 |
| 7169 | High light scatter reticulocyte count | GCST90002385 | 0.30 |
| 7170 | High cholesterol | GCST90475203 | 0.30 |
| 7171 | CD209/ITGAV ratio | GCST90313753 | 0.30 |
| 7172 | Phospholipids to Total Lipids in Small VLDL percentage | GCST90499902 | 0.30 |
| 7173 | DBI/TMSB10 ratio | GCST90314414 | 0.30 |
| 7174 | FADD/PPP1R2 ratio | GCST90314774 | 0.30 |
| 7175 | Oblique pelvic inlet length | GCST90448909 | 0.30 |
| 7176 | Rheumatoid arthritis | GCST90018690 | 0.30 |
| 7177 | NUCB2/TRIAP1 ratio | GCST90315577 | 0.30 |
| 7178 | CD300LG/TNFRSF1A ratio | GCST90313803 | 0.30 |
| 7179 | Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditions | UKBB00000510 | 0.29 |
| 7180 | SRC levels | GCST90470741 | 0.29 |
| 7181 | RWDD1 levels | GCST90470510 | 0.29 |
| 7182 | Skin yellow/blue component | GCST90320259 | 0.29 |
| 7183 | Cabbage liking | GCST90094719 | 0.29 |
| 7184 | Hernia of abdominal wall, postoperative | FING00000618 | 0.29 |
| 7185 | Monocyte count | GCST90018747 | 0.29 |
| 7186 | GCG levels | GCST90469316 | 0.29 |
| 7187 | Dermatophytosis / Dermatomycosis (PheCode 110) | GCST90475560 | 0.29 |
| 7188 | IDP dMRI ProbtrackX ICVF fmi | GCST90004386 | 0.29 |
| 7189 | T1 FreeSurfer BA rh BA2 exvivo volume | GCST90385576 | 0.29 |
| 7190 | rfMRI connectivity ICA-features 1 | GCST90006339 | 0.29 |
| 7191 | Cholesterol levels in medium HDL | GCST90092892 | 0.29 |
| 7192 | Accelerometer-based physical activity measurement (average acceleration) | GCST006099 | 0.29 |
| 7193 | SRPK2 levels | GCST90470743 | 0.29 |
| 7194 | AmygNuclei rh volume Medial-nucleus | GCST90002663 | 0.29 |
| 7195 | Sarcoidosis | FING00001275 | 0.29 |
| 7196 | Tea without sugar liking | GCST90094858 | 0.29 |
| 7197 | SH2B3 levels | GCST90470616 | 0.29 |
| 7198 | Estimated glomerular filtration rate, serum creatinine + cystain C | Other measurement | UKBB00000211 | 0.29 |
| 7199 | SPON1 levels | GCST90470731 | 0.29 |
| 7200 | KLK7 levels | GCST90469706 | 0.29 |
| 7201 | SCAMP3/VPS53 ratio | GCST90315807 | 0.29 |
| 7202 | DNM1 levels | GCST90469021 | 0.29 |
| 7203 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473 | ECGA000473 | 0.29 |
| 7204 | COL3A1 levels | GCST90468817 | 0.28 |
| 7205 | GPIHBP1 levels | GCST90469390 | 0.28 |
| 7206 | BCR/ICA1 ratio | GCST90313493 | 0.28 |
| 7207 | IPCEF1/TBCC ratio | GCST90315188 | 0.28 |
| 7208 | T1 FreeSurfer DK lh superiortemporal thickness | GCST90385651 | 0.28 |
| 7209 | PDGFC/TFPI ratio | GCST90315636 | 0.28 |
| 7210 | Plasma propionylcarnitine (C3) levels in chronic kidney disease | GCST90265876 | 0.28 |
| 7211 | ICAM1 levels | GCST90469498 | 0.28 |
| 7212 | Medication use (beta blocking agents) | GCST90018766 | 0.28 |
| 7213 | ICD10 O20: Haemorrhage in early pregnancy | GCST90454235 | 0.28 |
| 7214 | Schizophrenia or delusion (more control exclusions) | FING00001278 | 0.28 |
| 7215 | CFB levels | GCST90468723 | 0.28 |
| 7216 | Number of self-reported non-cancer illnesses | Medical conditions | UKBB00000541 | 0.28 |
| 7217 | PADI2 levels | GCST90470142 | 0.28 |
| 7218 | MSR1 levels | GCST90469950 | 0.28 |
| 7219 | RAB31 levels | GCST90087552 | 0.28 |
| 7220 | Lymphoid neoplasms (P-cell phenocluster) | GCST90624737 | 0.28 |
| 7221 | NSFL1C levels | GCST90470089 | 0.28 |
| 7222 | Other bacterial diseases | FING00000968 | 0.28 |
| 7223 | PDGFB/TIMP3 ratio | GCST90315631 | 0.28 |
| 7224 | Treatment speciality of consultant (recoded) - Dermatology | Summary Administration | UKBB00000830 | 0.28 |
| 7225 | ACY1 levels | GCST90468212 | 0.28 |
| 7226 | USP8/WASF1 ratio | GCST90315944 | 0.28 |
| 7227 | PLXNA4/SUSD1 ratio | GCST90315689 | 0.28 |
| 7228 | TBCB levels | GCST90470813 | 0.28 |
| 7229 | Otitis media and Eustachian tube disorders (PheCode 381) | GCST90475902 | 0.28 |
| 7230 | IDP dMRI TBSS ISOVF Posterior corona radiata R | GCST90004503 | 0.28 |
| 7231 | Cholesterol in small VLDL (UKB data field 23512) | GCST90269609 | 0.28 |
| 7232 | Sphingomyelin_33:1_[M+H]1+ levels | GCST90060229 | 0.28 |
| 7233 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499043 | 0.28 |
| 7234 | LAT/MANF ratio | GCST90315284 | 0.27 |
| 7235 | CASP7 levels | GCST90468547 | 0.27 |
| 7236 | AGER levels | GCST90012054 | 0.27 |
| 7237 | Mild age-related type 2 diabetes | GCST90026416 | 0.27 |
| 7238 | ICD10 N81: Female genital prolapse | GCST90454214 | 0.27 |
| 7239 | HMBS/PSMG3 ratio | GCST90315064 | 0.27 |
| 7240 | High light scatter reticulocyte percentage of red cells | GCST90002386 | 0.27 |
| 7241 | Gout (PheCode 274.1) | GCST90476379 | 0.27 |
| 7242 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454 | ECGU000454 | 0.27 |
| 7243 | MAVS/ZBTB16 ratio | GCST90315401 | 0.27 |
| 7244 | F-burn/spicy liking (derived food-liking factor) | GCST90094716 | 0.27 |
| 7245 | Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264328 | 0.27 |
| 7246 | ENDOU levels | GCST90469107 | 0.27 |
| 7247 | Coronary artery plaque burden | GCST90503075 | 0.27 |
| 7248 | Certain disorders involving the immune mechanism | FING00000264 | 0.27 |
| 7249 | KLK6 levels | GCST90469705 | 0.27 |
| 7250 | Type 2 diabetes | endocrine/metabolic | UKBB00000867 | 0.27 |
| 7251 | IDP dMRI TBSS ICVF Pontine crossing tract | GCST90004328 | 0.27 |
| 7252 | CCN3/COL6A3 ratio | GCST90313720 | 0.27 |
| 7253 | Omega-3 fatty acids to total fatty acids percentage | GCST90502460 | 0.27 |
| 7254 | 1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels | GCST90199652 | 0.27 |
| 7255 | CXCL5/EDAR ratio | GCST90314349 | 0.27 |
| 7256 | IDP T1 SIENAX grey unnormalised volume | GCST90002431 | 0.27 |
| 7257 | LY75 levels | GCST90469822 | 0.27 |
| 7258 | ST6GAL1 levels | GCST90470753 | 0.27 |
| 7259 | Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302817 | 0.27 |
| 7260 | Serum copper levels | GCST90100524 | 0.27 |
| 7261 | Telomere length (principal component 2) | GCST90435145 | 0.27 |
| 7262 | LBR levels | GCST90469744 | 0.27 |
| 7263 | aparc-Desikan rh volume fusiform | GCST90002807 | 0.27 |
| 7264 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479 | ECGA000479 | 0.27 |
| 7265 | SPINK5 levels | GCST90470724 | 0.27 |
| 7266 | Gastric cancer | GCST90018629 | 0.27 |
| 7267 | Vaginitis/vulvovaginitis/vulvitis/abscess of vulva | FING00001412 | 0.26 |
| 7268 | Tyrosine levels | GCST90500156 | 0.26 |
| 7269 | EIF4B levels | GCST90469094 | 0.26 |
| 7270 | aparc-DKTatlas lh volume parstriangularis | GCST90002880 | 0.26 |
| 7271 | IGF1 levels | GCST90102623 | 0.26 |
| 7272 | Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenum | UKBB00000606 | 0.26 |
| 7273 | LRG1 levels | GCST90469793 | 0.26 |
| 7274 | SPARCL1 levels | GCST90470717 | 0.26 |
| 7275 | Lymphoid leukemia, chronic (PheCode 204.12) | GCST90475613 | 0.26 |
| 7276 | IDP dMRI TBSS L1 Fornix | GCST90004080 | 0.26 |
| 7277 | Melanocytic naevi, other sites/unspecified | FING00000802 | 0.26 |
| 7278 | Triglyceride (52:5) levels | GCST90488320 | 0.26 |
| 7279 | FKBP5 levels | GCST90469244 | 0.26 |
| 7280 | NECTIN2/TNFRSF1A ratio | GCST90315532 | 0.26 |
| 7281 | AmygNuclei lh volume Central-nucleus | GCST90002652 | 0.26 |
| 7282 | RUVBL1 levels | GCST90470509 | 0.26 |
| 7283 | Cholesteryl ester (16:2) levels | GCST90024628 | 0.26 |
| 7284 | DBNL/EDAR ratio | GCST90314416 | 0.26 |
| 7285 | Benign neoplasm: Rectum, anus and anal canal | FING00000197 | 0.26 |
| 7286 | CD27 levels | GCST90468615 | 0.26 |
| 7287 | EZR levels | GCST90469162 | 0.26 |
| 7288 | GBP2 levels | GCST90469312 | 0.26 |
| 7289 | Pancreas volume | GCST90016669 | 0.26 |
| 7290 | SCARF1 levels | GCST90470536 | 0.26 |
| 7291 | Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626) | GCST90269723 | 0.26 |
| 7292 | Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivity | GCST90302724 | 0.26 |
| 7293 | IL1RL1 levels | GCST90469574 | 0.26 |
| 7294 | Glycated haemoglobin HbA1c levels (UKB data field 30750) | GCST90468072 | 0.26 |
| 7295 | Melanocytic naevi | FING00000797 | 0.26 |
| 7296 | Phosphatidylethanolamine (38:4) levels | GCST90488261 | 0.26 |
| 7297 | VTA1 levels | GCST90471058 | 0.26 |
| 7298 | ADAM12 levels | GCST90468216 | 0.26 |
| 7299 | High light scatter reticulocyte percentage | Blood count | UKBB00000327 | 0.26 |
| 7300 | RNASE3 levels | GCST90470477 | 0.26 |
| 7301 | CD200/CNTNAP2 ratio | GCST90313747 | 0.26 |
| 7302 | MXRA8 levels | GCST90469968 | 0.26 |
| 7303 | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302719 | 0.26 |
| 7304 | potassium (mean, inv-norm transformed) | GCST90476307 | 0.26 |
| 7305 | ERBB3/IL1R2 ratio | GCST90314689 | 0.26 |
| 7306 | NPL levels | GCST90470072 | 0.26 |
| 7307 | Attention deficit hyperactivity disorder | GCST90568441 | 0.26 |
| 7308 | DTI TBSS MD Anterior corona radiata L | GCST90384595 | 0.26 |
| 7309 | CD38/IL12A_IL12B ratio | GCST90313808 | 0.26 |
| 7310 | aparc-a2009s rh volume G-parietal-sup | GCST90003025 | 0.25 |
| 7311 | Cholesteryl esters in small VLDL (UKB data field 23513) | GCST90269610 | 0.25 |
| 7312 | Low-density lipoprotein levels (MTAG) | GCST90179148 | 0.25 |
| 7313 | Lysophosphatidylcholine (20:3) [sn1] levels | GCST90024169 | 0.25 |
| 7314 | FOXO1/USP8 ratio | GCST90314879 | 0.25 |
| 7315 | Cholesteryl Esters in Large LDL | GCST90497955 | 0.25 |
| 7316 | CLEC14A/PIK3IP1 ratio | GCST90314080 | 0.25 |
| 7317 | ICAM3/TNFRSF13B ratio | GCST90315124 | 0.25 |
| 7318 | FBLN2 levels | GCST90469193 | 0.25 |
| 7319 | Octadecanedioylcarnitine (C18-DC) levels | GCST90199992 | 0.25 |
| 7320 | DNAJA2 levels | GCST90469009 | 0.25 |
| 7321 | Treatment/medication code - amlodipine | Medications | UKBB00000840 | 0.25 |
| 7322 | DSC2 levels | GCST90469040 | 0.25 |
| 7323 | Non-insulin-dependent diabetes mellitus | Diabetes mellitus | UKBB00000524 | 0.25 |
| 7324 | Alanine levels | GCST90497086 | 0.25 |
| 7325 | BMI (weighted GWA) | GCST90267269 | 0.25 |
| 7326 | Total lipids in medium LDL (UKB data field 23538) | GCST90269635 | 0.25 |
| 7327 | DCXR/SCLY ratio | GCST90314440 | 0.25 |
| 7328 | ATOX1 levels | GCST90468385 | 0.25 |
| 7329 | TRIAP1 levels | GCST90470963 | 0.25 |
| 7330 | DTI TBSS L3 Anterior corona radiata R | GCST90384546 | 0.25 |
| 7331 | IL7 levels | GCST90469606 | 0.25 |
| 7332 | White blood cell count | GCST90018758 | 0.25 |
| 7333 | IGSF8 levels | GCST90469540 | 0.25 |
| 7334 | CHMP1A levels | GCST90468746 | 0.25 |
| 7335 | INPP1/TBCC ratio | GCST90315180 | 0.25 |
| 7336 | F-sodas liking (derived food-liking factor) | GCST90094842 | 0.25 |
| 7337 | SNAP25 levels | GCST90470691 | 0.25 |
| 7338 | Total diffusion tensor imaging along the perivascular space index | GCST90455546 | 0.25 |
| 7339 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320825 | 0.25 |
| 7340 | DOK1 levels | GCST90469028 | 0.25 |
| 7341 | TBCB/TBCC ratio | GCST90315909 | 0.25 |
| 7342 | Estimated glomerular filtration rate (cystatin c) | GCST90428448 | 0.25 |
| 7343 | Body fat percentage (adjusted for testosterone and SHBG) x sex interaction | GCST90432181 | 0.25 |
| 7344 | CTRB1 levels | GCST90468905 | 0.25 |
| 7345 | Phenylacetate levels | GCST90199630 | 0.24 |
| 7346 | aparc-DKTatlas rh volume fusiform | GCST90002898 | 0.24 |
| 7347 | ENPP6 levels | GCST90469117 | 0.24 |
| 7348 | ADGRF5 levels | GCST90468239 | 0.24 |
| 7349 | Volume of right central nucleus | GCST90475027 | 0.24 |
| 7350 | CD40 levels | GCST90468633 | 0.24 |
| 7351 | NADK levels | GCST90469993 | 0.24 |
| 7352 | High density lipoprotein cholesterol levels | GCST90239651 | 0.24 |
| 7353 | Total concentration of lipoprotein particles (UKB data field 23427) | GCST90269524 | 0.24 |
| 7354 | Indolelactate levels | GCST90243507 | 0.24 |
| 7355 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228 | ECGU000228 | 0.24 |
| 7356 | ADA2/COMP ratio | GCST90313166 | 0.24 |
| 7357 | CACNA2D3 levels | GCST90243348 | 0.24 |
| 7358 | CTSB levels | GCST90468908 | 0.24 |
| 7359 | neutrophil (absolute count, minimum, inv-norm transformed) | GCST90475532 | 0.24 |
| 7360 | Operative procedures - Total cholecystectomy NEC | Summary Operations | UKBB00000589 | 0.24 |
| 7361 | Peptic ulcer disease | GCST90270926 | 0.24 |
| 7362 | TOMM20 levels | GCST90470931 | 0.24 |
| 7363 | DLK1/FAP ratio | GCST90314491 | 0.24 |
| 7364 | ABL1/CC2D1A ratio | GCST90313148 | 0.24 |
| 7365 | Left-hemisphere control network to pallidum white-matter structural connectivity | GCST90302755 | 0.24 |
| 7366 | KAZN levels | GCST90469666 | 0.24 |
| 7367 | ANPEP levels | GCST90468313 | 0.24 |
| 7368 | Free cholesterol levels in very large HDL | GCST90093008 | 0.24 |
| 7369 | Total lipids in very large HDL | GCST90500423 | 0.24 |
| 7370 | Creatinine levels | GCST90497236 | 0.24 |
| 7371 | Frequency of stair climbing in last 4 weeks | Physical activity | UKBB00000266 | 0.24 |
| 7372 | CD27/FCRL5 ratio | GCST90313772 | 0.24 |
| 7373 | DCTN6/TDRKH ratio | GCST90314436 | 0.24 |
| 7374 | MTIF3 levels | GCST90469957 | 0.24 |
| 7375 | Concentration of small VLDL particles | GCST90092975 | 0.23 |
| 7376 | Multiple myeloma or monoclonal gammopathy of undetermined significance | GCST90624746 | 0.23 |
| 7377 | VASN levels | GCST90471027 | 0.23 |
| 7378 | GIPC3 levels | GCST90469348 | 0.23 |
| 7379 | T1 FreeSurfer DKT lh superiortemporal thickness | GCST90384252 | 0.23 |
| 7380 | CASP8/PRDX6 ratio | GCST90313655 | 0.23 |
| 7381 | Other diseases of blood and blood-forming organs, wide | FING00000999 | 0.23 |
| 7382 | ANXA4/FADD ratio | GCST90313291 | 0.23 |
| 7383 | Phospholipids in small HDL (UKB data field 23574) | GCST90269671 | 0.23 |
| 7384 | MPI levels | GCST90469936 | 0.23 |
| 7385 | End-diastolic bi-ventricular shape (principal component 2) | GCST90448481 | 0.23 |
| 7386 | Linoleic acid levels (UKB data field 23449) | GCST90269546 | 0.23 |
| 7387 | rfMRI connectivity (ICA25 edge 103) | GCST90004746 | 0.23 |
| 7388 | Phospholipid levels in medium HDL | GCST90092900 | 0.23 |
| 7389 | VLDL cholesterol levels | GCST90500196 | 0.23 |
| 7390 | Total lipid levels in small VLDL | GCST90092974 | 0.23 |
| 7391 | MPO levels | GCST90012031 | 0.23 |
| 7392 | IFNGR2 levels | GCST90469514 | 0.23 |
| 7393 | Clonal hematopoiesis (DNMT3A mutation) | GCST90435354 | 0.23 |
| 7394 | GP6 levels | GCST90469384 | 0.23 |
| 7395 | DAB2/LYN ratio | GCST90314365 | 0.23 |
| 7396 | Phosphatidylcholines levels (UKB data field 23437) | GCST90269534 | 0.23 |
| 7397 | Principal component-derived dietary pattern 46 | GCST90133051 | 0.23 |
| 7398 | MYBPC1 levels | GCST90469969 | 0.23 |
| 7399 | CCL21 levels | GCST90468573 | 0.23 |
| 7400 | Alanine transaminase (ALT, mean, inv-norm transformed) | GCST90475112 | 0.23 |
| 7401 | ATXN2L levels | GCST90468402 | 0.23 |
| 7402 | Cholesterol in medium LDL (UKB data field 23540) | GCST90269637 | 0.23 |
| 7403 | CXCL1 levels | GCST90468930 | 0.23 |
| 7404 | Congenital malformations of heart and great arteries | FING00000336 | 0.23 |
| 7405 | Cardiac dysrhythmias | circulatory system | UKBB00000119 | 0.23 |
| 7406 | TFF2 levels | GCST90470836 | 0.23 |
| 7407 | EREG/ITGB1BP2 ratio | GCST90314703 | 0.23 |
| 7408 | Glycoprotein acetyls levels (UKB data field 23480) | GCST90269577 | 0.23 |
| 7409 | PLXNA4 levels | GCST90470265 | 0.23 |
| 7410 | Polyunsaturated fatty acid levels | GCST90092939 | 0.23 |
| 7411 | PLIN3 levels | GCST90470259 | 0.23 |
| 7412 | RGMB/SMOC2 ratio | GCST90315770 | 0.22 |
| 7413 | FABP5 levels | GCST90469177 | 0.22 |
| 7414 | EIF4G1 levels | GCST90469097 | 0.22 |
| 7415 | Physical activity | GCST90093324 | 0.22 |
| 7416 | Disorders of plasma-protein metabolism, not elsewhere classified | FING00000455 | 0.22 |
| 7417 | Percentage of M9 (GP18) | GCST90668462 | 0.22 |
| 7418 | Omega-6 fatty acids levels (UKB data field 23445) | GCST90269542 | 0.22 |
| 7419 | Low density lipoprotein cholesterol levels | GCST90002412 | 0.22 |
| 7420 | ITGA5 levels | GCST90469635 | 0.22 |
| 7421 | Right ventricular end diastolic volume (MTAG) | GCST90134592 | 0.22 |
| 7422 | MYOM3 levels | GCST90469986 | 0.22 |
| 7423 | Phospholipids in HDL (UKB data field 23414) | GCST90269511 | 0.22 |
| 7424 | Restless legs syndrome (PheCode 327.71) | GCST90475829 | 0.22 |
| 7425 | TDP1 levels | GCST90470826 | 0.22 |
| 7426 | HBEGF/LAT2 ratio | GCST90315032 | 0.22 |
| 7427 | Triglycerides in small HDL | GCST90499516 | 0.22 |
| 7428 | CCL13/CCL17 ratio | GCST90313674 | 0.22 |
| 7429 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) | GCST90092984 | 0.22 |
| 7430 | MAVS/MZT1 ratio | GCST90315391 | 0.22 |
| 7431 | Triglycerides in very large HDL | GCST90500482 | 0.22 |
| 7432 | TNFRSF1A levels | GCST90470910 | 0.22 |
| 7433 | TIA1 levels | GCST90470862 | 0.22 |
| 7434 | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels | GCST90199853 | 0.22 |
| 7435 | Cholesteryl Esters in HDL | GCST90497357 | 0.22 |
| 7436 | Operative procedures - Haemorrhoidectomy | Summary Operations | UKBB00000580 | 0.22 |
| 7437 | ITGAV levels | GCST90469639 | 0.22 |
| 7438 | VLDL cholesterol levels | GCST90092996 | 0.22 |
| 7439 | Essential tremor (PheCode 333.1) | GCST90475832 | 0.22 |
| 7440 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481 | ECGA000481 | 0.22 |
| 7441 | DPY30 levels | GCST90469037 | 0.22 |
| 7442 | Neutrophil count | GCST90025977 | 0.22 |
| 7443 | CDH17/GALNT3 ratio | GCST90313940 | 0.22 |
| 7444 | Varicose veins (PheCode 454) | GCST90476012 | 0.22 |
| 7445 | APOA1 levels | GCST90092808 | 0.22 |
| 7446 | CCL4 levels | GCST004433 | 0.22 |
| 7447 | LTBR/SIRPB1 ratio | GCST90315339 | 0.22 |
| 7448 | Takes medication for Skin condition (ex. Eczema, Psoriasis)? | GCST90475275 | 0.22 |
| 7449 | All pneumoniae | FING00000065 | 0.21 |
| 7450 | Hemoglobin concentration | GCST004615 | 0.21 |
| 7451 | HMOX1 levels | GCST90469465 | 0.21 |
| 7452 | Total lipid levels in medium HDL | GCST90092898 | 0.21 |
| 7453 | High light scatter reticulocyte count | Blood count | UKBB00000326 | 0.21 |
| 7454 | Cholesteryl ester levels in medium HDL | GCST90092894 | 0.21 |
| 7455 | TNFRSF4/TNFRSF8 ratio | GCST90315938 | 0.21 |
| 7456 | CDKN1A/HBEGF ratio | GCST90313972 | 0.21 |
| 7457 | CD46 levels | GCST90468634 | 0.21 |
| 7458 | Concentration of medium HDL particles | GCST90092899 | 0.21 |
| 7459 | CSRP3 levels | GCST90468892 | 0.21 |
| 7460 | Eosinophil count | GCST90018733 | 0.21 |
| 7461 | Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels | GCST90060298 | 0.21 |
| 7462 | MITD1 levels | GCST90469910 | 0.21 |
| 7463 | BLMH/PEAR1 ratio | GCST90313519 | 0.21 |
| 7464 | GM2A levels | GCST90469365 | 0.21 |
| 7465 | High density lipoprotein cholesterol levels | GCST90278635 | 0.21 |
| 7466 | Total body bone mineral density (age 0-15) | GCST005345 | 0.21 |
| 7467 | Horseradish liking | GCST90094783 | 0.21 |
| 7468 | TNFRSF11A levels | GCST90277644 | 0.21 |
| 7469 | Ever depressed for a whole week | Mental health | UKBB00000214 | 0.21 |
| 7470 | TMEM25 levels | GCST90470888 | 0.21 |
| 7471 | Total fatty acid levels | GCST90502710 | 0.21 |
| 7472 | HSPB1 levels | GCST90469489 | 0.21 |
| 7473 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500 | ECGU000500 | 0.21 |
| 7474 | NID2 levels | GCST90470048 | 0.21 |
| 7475 | STAT2 levels | GCST90470758 | 0.21 |
| 7476 | Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621) | GCST90269718 | 0.21 |
| 7477 | HEXIM1/TRIAP1 ratio | GCST90315054 | 0.21 |
| 7478 | CD27/TNFRSF9 ratio | GCST90313778 | 0.21 |
| 7479 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480 | ECGA000480 | 0.21 |
| 7480 | GOLM2/ITGA5 ratio | GCST90314951 | 0.21 |
| 7481 | FOXO1/MAP4K5 ratio | GCST90314872 | 0.21 |
| 7482 | aparc-DKTatlas lh volume supramarginal | GCST90002891 | 0.21 |
| 7483 | NTRK3 levels | GCST90470098 | 0.21 |
| 7484 | MAX levels | GCST90469867 | 0.21 |
| 7485 | SNX9 levels | GCST90470703 | 0.21 |
| 7486 | HBEGF/PDGFA ratio | GCST90315033 | 0.21 |
| 7487 | Systolic blood pressure | GCST90025968 | 0.21 |
| 7488 | Total lipids in HDL (UKB data field 23426) | GCST90269523 | 0.21 |
| 7489 | Cholesteryl Esters in Small VLDL | GCST90499782 | 0.21 |
| 7490 | Plasma N-acetylhistidine levels in chronic kidney disease | GCST90265576 | 0.21 |
| 7491 | Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels | GCST90060243 | 0.21 |
| 7492 | Sphingomyelin_40:0_[M+H]1+ levels | GCST90060364 | 0.20 |
| 7493 | BIN2/PDLIM7 ratio | GCST90313509 | 0.20 |
| 7494 | DTI TBSS MD Splenium of corpus callosum | GCST90384576 | 0.20 |
| 7495 | Haddock liking | GCST90094776 | 0.20 |
| 7496 | Dried fruit consumption | GCST90132980 | 0.20 |
| 7497 | CILP levels | GCST90468754 | 0.20 |
| 7498 | Psoriatic arthritis vs Cutaneous psoriasis | GCST90243957 | 0.20 |
| 7499 | aseg lh intensity Inf-Lat-Vent | GCST90003765 | 0.20 |
| 7500 | NAA80 levels | GCST90469990 | 0.20 |
| 7501 | IMPA1 levels | GCST90469610 | 0.20 |
| 7502 | BANK1 levels | GCST90468421 | 0.20 |
| 7503 | QSOX1 levels | GCST90470402 | 0.20 |
| 7504 | MEP1B levels | GCST90469888 | 0.20 |
| 7505 | Cholesterol levels in small VLDL | GCST90092968 | 0.20 |
| 7506 | ALCAM/MSR1 ratio | GCST90313240 | 0.20 |
| 7507 | Excessive scarring | GCST90483368 | 0.20 |
| 7508 | MNDA levels | GCST90469927 | 0.20 |
| 7509 | CD274 levels | GCST90468613 | 0.20 |
| 7510 | Reason for glasses/contact lenses - For 'astigmatism' | Eyesight | UKBB00000733 | 0.20 |
| 7511 | CNTN2 levels | GCST90468804 | 0.20 |
| 7512 | Main speciality of consultant (recoded) - Gastroenterology | Summary Administration | UKBB00000415 | 0.20 |
| 7513 | Mineral and other dietary supplements - Fish oil (including cod liver oil) | Medication | UKBB00000472 | 0.20 |
| 7514 | Total phospholipid levels in lipoprotein particles | GCST90500124 | 0.20 |
| 7515 | CA2/NSFL1C ratio | GCST90313580 | 0.20 |
| 7516 | C1QTNF9 levels | GCST90468491 | 0.20 |
| 7517 | Breathing problems during period of job | Employment history | UKBB00000111 | 0.20 |
| 7518 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499 | ECGA000499 | 0.20 |
| 7519 | Venous thromboembolism | GCST90399744 | 0.20 |
| 7520 | platelet count (maximum, inv-norm transformed) | GCST90476296 | 0.20 |
| 7521 | NUDT2 levels | GCST90470106 | 0.20 |
| 7522 | Homeostasis model assessment of beta-cell function | GCST005180 | 0.20 |
| 7523 | STC2 levels | GCST90470762 | 0.20 |
| 7524 | QC SWI-to-T1 linear alignment discrepancy | GCST90006352 | 0.20 |
| 7525 | JPT2 levels | GCST90469663 | 0.20 |
| 7526 | 4-androsten-3beta,17beta-diol disulfate 2 levels | GCST90243880 | 0.20 |
| 7527 | Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary Operations | UKBB00000591 | 0.20 |
| 7528 | Free androgen index | GCST90239824 | 0.20 |
| 7529 | WWP2 levels | GCST90471080 | 0.20 |
| 7530 | HDL x depression interaction (2df test) | GCST90570667 | 0.19 |
| 7531 | Platelet count | GCST90002402 | 0.19 |
| 7532 | PTPN6 levels | GCST90470377 | 0.19 |
| 7533 | Alzheimer's disease | GCST90027158 | 0.19 |
| 7534 | Age high blood pressure diagnosed | Medical conditions | UKBB00000016 | 0.19 |
| 7535 | ELOA levels | GCST90469104 | 0.19 |
| 7536 | Personality disorders (more control exclusions) | FING00001163 | 0.19 |
| 7537 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449 | ECGU000449 | 0.19 |
| 7538 | Endometriosis of ovary | FING00000501 | 0.19 |
| 7539 | Frequency of unenthusiasm / disinterest in last 2 weeks | Mental health | UKBB00000270 | 0.19 |
| 7540 | SERPINB13 levels | GCST90423326 | 0.19 |
| 7541 | Omega-3 fatty acids to total fatty acids percentage | GCST90499155 | 0.19 |
| 7542 | CXCL11/ITGB1BP2 ratio | GCST90314335 | 0.19 |
| 7543 | aseg lh volume Lateral-Ventricle | GCST90002616 | 0.19 |
| 7544 | C20:4 Lysophosphatidylcholine levels in chronic kidney disease | GCST90257570 | 0.19 |
| 7545 | MGMT levels | GCST90469902 | 0.19 |
| 7546 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 0.19 |
| 7547 | CD6/EZR ratio | GCST90313890 | 0.19 |
| 7548 | COMT levels | GCST90468828 | 0.19 |
| 7549 | Breast cancer | neoplasms | UKBB00000109 | 0.19 |
| 7550 | Strenuous sports or other exercises | GCST006100 | 0.19 |
| 7551 | SERPINA11 levels | GCST90470580 | 0.19 |
| 7552 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668758 | 0.19 |
| 7553 | Phosphoglycerides levels | GCST90092938 | 0.19 |
| 7554 | Facial wrinkles (under eye) | GCST90094903 | 0.19 |
| 7555 | Emotionally unstable personality disorder | FING00000495 | 0.19 |
| 7556 | CRKL levels | GCST90468867 | 0.19 |
| 7557 | Treatment/medication code - gliclazide | Medications | UKBB00000846 | 0.19 |
| 7558 | ANXA3 levels | GCST90468318 | 0.19 |
| 7559 | PPP1R2/USP8 ratio | GCST90315723 | 0.19 |
| 7560 | PDE5A levels | GCST90470187 | 0.19 |
| 7561 | ACP6 levels | GCST90468204 | 0.19 |
| 7562 | Unstable angina (intermediate coronary syndrome) | circulatory system | UKBB00000883 | 0.19 |
| 7563 | DTI autoptx L1 cst l tract | GCST90385147 | 0.19 |
| 7564 | Total concentration of lipoprotein particles | GCST90092990 | 0.19 |
| 7565 | EDAR/EGF ratio | GCST90314573 | 0.19 |
| 7566 | Right-hemisphere control network to putamen white-matter structural connectivity | GCST90302838 | 0.19 |
| 7567 | CANT1/ROR1 ratio | GCST90313620 | 0.19 |
| 7568 | aparc-pial rh area fusiform | GCST90003180 | 0.19 |
| 7569 | Red cell distribution width variance | GCST90565705 | 0.19 |
| 7570 | CA9 levels | GCST90468518 | 0.18 |
| 7571 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502075 | 0.18 |
| 7572 | PLA2G10 levels | GCST90470244 | 0.18 |
| 7573 | Glucose levels | GCST90092819 | 0.18 |
| 7574 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487 | ECGA000487 | 0.18 |
| 7575 | CD5/CD6 ratio | GCST90313860 | 0.18 |
| 7576 | F-fatty food liking (derived food-liking factor) | GCST90094761 | 0.18 |
| 7577 | GPRC5C levels | GCST90469398 | 0.18 |
| 7578 | LACTB2 levels | GCST90469726 | 0.18 |
| 7579 | EDAR/ENO2 ratio | GCST90314574 | 0.18 |
| 7580 | Duodenal ulcer | GCST90270928 | 0.18 |
| 7581 | rfMRI connectivity ICA-features 6 | GCST90006344 | 0.18 |
| 7582 | Rotator cuff injury | GCST90044700 | 0.18 |
| 7583 | CACNB3 levels | GCST90468523 | 0.18 |
| 7584 | Other diseases of blood and blood-forming organs | FING00000998 | 0.18 |
| 7585 | GAL levels | GCST90469300 | 0.18 |
| 7586 | Childhood body mass index | GCST90002409 | 0.18 |
| 7587 | Verbal-numerical reasoning | GCST003498 | 0.18 |
| 7588 | Temporomandibular joint disorders | FING00001354 | 0.18 |
| 7589 | wg lh intensity-contrast frontalpole | GCST90003823 | 0.18 |
| 7590 | ATG16L1 levels | GCST90468383 | 0.18 |
| 7591 | BA-exvivo rh thickness BA2 | GCST90003528 | 0.18 |
| 7592 | Reticulocyte percentage (UKB data field 30240) | GCST90468101 | 0.18 |
| 7593 | DTI autoptx L2 ifo l tract | GCST90385178 | 0.18 |
| 7594 | aparc-pial lh area supramarginal | GCST90003171 | 0.18 |
| 7595 | CXCL14 levels | GCST90468927 | 0.18 |
| 7596 | Cholelithiasis | FING00000275 | 0.18 |
| 7597 | Enthesopathy (PheCode 726.1) | GCST90476239 | 0.18 |
| 7598 | CDH17/DSG2 ratio | GCST90313939 | 0.18 |
| 7599 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3 | ECGA000003 | 0.18 |
| 7600 | rfMRI amplitudes (ICA100 node 38) | GCST90004626 | 0.18 |
| 7601 | Plasma 4-guanidinobutanoate levels in chronic kidney disease | GCST90264620 | 0.18 |
| 7602 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 0.18 |
| 7603 | BA-exvivo lh area BA6 | GCST90003213 | 0.18 |
| 7604 | DAG1/HBEGF ratio | GCST90314376 | 0.18 |
| 7605 | RAP1A levels | GCST90470425 | 0.18 |
| 7606 | SNX2 levels | GCST90470701 | 0.18 |
| 7607 | Red blood cell count | GCST90002403 | 0.18 |
| 7608 | Triglycerides in small HDL | GCST90499519 | 0.18 |
| 7609 | Saturated fatty acids to total fatty acids percentage | GCST90499966 | 0.18 |
| 7610 | CD58/LTBR ratio | GCST90313851 | 0.18 |
| 7611 | MAP3K5/MAVS ratio | GCST90315379 | 0.18 |
| 7612 | DCTN1 levels | GCST90468958 | 0.18 |
| 7613 | GRP levels | GCST90241242 | 0.18 |
| 7614 | Treatment/medication code - co-codamol | Medications | UKBB00000845 | 0.17 |
| 7615 | Cervicalgia (PheCode 761) | GCST90476267 | 0.17 |
| 7616 | CD58/TYRO3 ratio | GCST90313856 | 0.17 |
| 7617 | HDL cholesterol levels | GCST90497340 | 0.17 |
| 7618 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10 | ECGA000010 | 0.17 |
| 7619 | Red blood cell erythrocyte count (UKB data field 30010) | GCST90468098 | 0.17 |
| 7620 | Linoleic acid levels | GCST90092880 | 0.17 |
| 7621 | Malignant neoplasm of female breast (PheCode 174.11) | GCST90041833 | 0.17 |
| 7622 | HSIL lesion of the vulva | FING00000626 | 0.17 |
| 7623 | Fluid intelligence score decline (difference score) | GCST90565862 | 0.17 |
| 7624 | Age spots | GCST006096 | 0.17 |
| 7625 | F-chocolate/coffee liking (derived food-liking factor) | GCST90094735 | 0.17 |
| 7626 | CD84/SEMA4D ratio | GCST90313917 | 0.17 |
| 7627 | Smoked fish liking | GCST90094841 | 0.17 |
| 7628 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497 | ECGU000497 | 0.17 |
| 7629 | ANPEP/DPP4 ratio | GCST90313273 | 0.17 |
| 7630 | RNF43 levels | GCST90470486 | 0.17 |
| 7631 | Omega-6 fatty acids to total fatty acids percentage | GCST90499210 | 0.17 |
| 7632 | PRRT3 levels | GCST90470340 | 0.17 |
| 7633 | Docosahexaenoic acid to total fatty acids percentage | GCST90502285 | 0.17 |
| 7634 | PECAM1/SOD2 ratio | GCST90315647 | 0.17 |
| 7635 | NIT2 levels | GCST90470051 | 0.17 |
| 7636 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427 | ECGU000427 | 0.17 |
| 7637 | CDH5 levels | GCST90468676 | 0.17 |
| 7638 | CD69/EDAR ratio | GCST90313875 | 0.17 |
| 7639 | PDGFC levels | GCST90470190 | 0.17 |
| 7640 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4 | ECGA000004 | 0.17 |
| 7641 | EBAG9 levels | GCST90469059 | 0.17 |
| 7642 | WFIKKN1 levels | GCST90471076 | 0.17 |
| 7643 | KL levels | GCST90091246 | 0.17 |
| 7644 | EIF4G1/FOXO1 ratio | GCST90314634 | 0.17 |
| 7645 | PODXL2/SDC1 ratio | GCST90315701 | 0.17 |
| 7646 | T1 FreeSurfer a2009s rh G cuneus volume | GCST90385048 | 0.17 |
| 7647 | ACVRL1/TNFRSF19 ratio | GCST90313159 | 0.16 |
| 7648 | Flat foot (PheCode 735.1) | GCST90476248 | 0.16 |
| 7649 | ICAM3/LY9 ratio | GCST90315121 | 0.16 |
| 7650 | TBCC/WWP2 ratio | GCST90315911 | 0.16 |
| 7651 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 0.16 |
| 7652 | FGF23 levels | GCST90469223 | 0.16 |
| 7653 | End stage renal disease (PheCode 585.32) | GCST90476126 | 0.16 |
| 7654 | Omega-6 fatty acid levels | GCST90502502 | 0.16 |
| 7655 | BRAP levels | GCST90468464 | 0.16 |
| 7656 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 0.16 |
| 7657 | BTC levels | GCST90468476 | 0.16 |
| 7658 | DYNLT1 levels | GCST90469057 | 0.16 |
| 7659 | IDP T1 FAST ROIs L thalamus | GCST90002547 | 0.16 |
| 7660 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule R | GCST90004095 | 0.16 |
| 7661 | IL18 levels | GCST90428411 | 0.16 |
| 7662 | Triglycerides to total lipids ratio in large HDL | GCST90092855 | 0.16 |
| 7663 | ITGA6/THPO ratio | GCST90315208 | 0.16 |
| 7664 | LEPR/NTRK2 ratio | GCST90315313 | 0.16 |
| 7665 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498 | ECGU000498 | 0.16 |
| 7666 | Otosclerosis | GCST90129575 | 0.16 |
| 7667 | NFASC levels | GCST90470031 | 0.16 |
| 7668 | VAMP5 levels | GCST90471024 | 0.16 |
| 7669 | CPB1/KIRREL2 ratio | GCST90314210 | 0.16 |
| 7670 | Polyunsaturated fatty acid levels | GCST90502606 | 0.16 |
| 7671 | Depression | FING00000398 | 0.16 |
| 7672 | CCER2 levels | GCST90468563 | 0.16 |
| 7673 | MIF levels | GCST90469906 | 0.16 |
| 7674 | Cholesteryl Esters in VLDL | GCST90500211 | 0.16 |
| 7675 | CCL25/PRSS27 ratio | GCST90313694 | 0.16 |
| 7676 | TMED8 levels | GCST90470885 | 0.16 |
| 7677 | OXCT1 levels | GCST90470138 | 0.16 |
| 7678 | T1 FreeSurfer DK lh precentral thickness | GCST90385645 | 0.16 |
| 7679 | MAPK13 levels | GCST90241949 | 0.16 |
| 7680 | SCAMP3 levels | GCST90470532 | 0.16 |
| 7681 | AGRP levels | GCST90012063 | 0.16 |
| 7682 | APOA2 levels | GCST90468332 | 0.16 |
| 7683 | IDP dMRI TBSS MD Posterior limb of internal capsule L | GCST90004046 | 0.16 |
| 7684 | VWC2 levels | GCST90471064 | 0.16 |
| 7685 | Cholesterol levels in very large HDL | GCST90093004 | 0.16 |
| 7686 | Gout, strict definition | FING00000588 | 0.16 |
| 7687 | Hematocrit | GCST004604 | 0.16 |
| 7688 | MSR1/TNFRSF21 ratio | GCST90315494 | 0.16 |
| 7689 | X-12411 levels | GCST90200492 | 0.15 |
| 7690 | PLA2G7 levels | GCST90470249 | 0.15 |
| 7691 | FCN1 levels | GCST90618565 | 0.15 |
| 7692 | PYDC1 levels | GCST90470397 | 0.15 |
| 7693 | Left-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302706 | 0.15 |
| 7694 | Postinfectious hypothyroidism | FING00001192 | 0.15 |
| 7695 | Concentration of HDL particles | GCST90092826 | 0.15 |
| 7696 | NPTX2 levels | GCST90470079 | 0.15 |
| 7697 | Blood cell traits latent factor 4 (red cell) | GCST90559246 | 0.15 |
| 7698 | SUMF2 levels | GCST90470784 | 0.15 |
| 7699 | Alkenylphosphatidylethanolamine (P-20:0/18:2) levels | GCST90025056 | 0.15 |
| 7700 | PCDH17/THBD ratio | GCST90315607 | 0.15 |
| 7701 | Obesity, other/unspecified | FING00000898 | 0.15 |
| 7702 | Cholesteryl Esters in Small LDL | GCST90499578 | 0.15 |
| 7703 | GRSF1 levels | GCST90469407 | 0.15 |
| 7704 | C1S levels | GCST90468494 | 0.15 |
| 7705 | Cholesterol in Large HDL | GCST90497719 | 0.15 |
| 7706 | Free cholesterol in medium HDL | GCST90498563 | 0.15 |
| 7707 | Platelet count (UKB data field 30080) | GCST90468095 | 0.15 |
| 7708 | CSNK1D levels | GCST90468888 | 0.15 |
| 7709 | Effects radiation NOS (PheCode 990) | GCST90476293 | 0.15 |
| 7710 | Keratoconus | FING00000709 | 0.15 |
| 7711 | aparc-Desikan lh volume supramarginal | GCST90002798 | 0.15 |
| 7712 | JAM2/TNFRSF21 ratio | GCST90315242 | 0.15 |
| 7713 | Octadecenedioylcarnitine (C18:1-DC) levels | GCST90199970 | 0.15 |
| 7714 | DVT of lower extremities | FING00000482 | 0.15 |
| 7715 | neutrophil (absolute count, mean, inv-norm transformed) | GCST90475529 | 0.15 |
| 7716 | Plateletcrit | GCST90002400 | 0.15 |
| 7717 | B4GAT1 levels | GCST90468413 | 0.15 |
| 7718 | CDH6 levels | GCST90468677 | 0.15 |
| 7719 | CD6 levels | GCST90468644 | 0.15 |
| 7720 | Dermatitis due to ingested food | FING00000403 | 0.15 |
| 7721 | TPD52L2 levels | GCST90470942 | 0.15 |
| 7722 | Right-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302811 | 0.15 |
| 7723 | CPB1/CTRC ratio | GCST90314209 | 0.15 |
| 7724 | wg rh intensity-contrast postcentral | GCST90003848 | 0.15 |
| 7725 | Aspartate aminotransferase levels | GCST90278618 | 0.15 |
| 7726 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 0.15 |
| 7727 | Keloid | GCST90652488 | 0.15 |
| 7728 | triglyceride (mean, inv-norm transformed) | GCST90476435 | 0.15 |
| 7729 | NUDT16 levels | GCST90470105 | 0.15 |
| 7730 | CDHR2/MME ratio | GCST90313963 | 0.15 |
| 7731 | FOXO1/IRAK4 ratio | GCST90314870 | 0.15 |
| 7732 | Operation code - hip replacement/revision | Operations | UKBB00000558 | 0.15 |
| 7733 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499302 | 0.15 |
| 7734 | Coxarthrosis | FING00000362 | 0.15 |
| 7735 | GPLD1 levels | GCST90086890 | 0.15 |
| 7736 | ICD10 O42: Premature rupture of membranes | GCST90454238 | 0.15 |
| 7737 | Right-hemisphere control network to accumbens white-matter structural connectivity | GCST90302842 | 0.15 |
| 7738 | Major dietary changes in the last 5 years - Yes, because of illness | Diet | UKBB00000422 | 0.15 |
| 7739 | aparc-DKTatlas lh area supramarginal | GCST90003263 | 0.15 |
| 7740 | aparc-DKTatlas rh thickness postcentral | GCST90003591 | 0.15 |
| 7741 | Gestational age at birth (maternal effect) | GCST90268419 | 0.15 |
| 7742 | Leisure/social activities - None of the above | Social support | UKBB00000399 | 0.15 |
| 7743 | Parental longevity (combined parental age at death) | GCST006702 | 0.15 |
| 7744 | F3 levels | GCST90012014 | 0.15 |
| 7745 | MNX1 levels | GCST90090758 | 0.15 |
| 7746 | Platelet count | Blood count | UKBB00000646 | 0.15 |
| 7747 | CDC37/PPP1R12A ratio | GCST90313934 | 0.14 |
| 7748 | SULT1A1 levels | GCST90470781 | 0.14 |
| 7749 | Omega-6 fatty acid levels | GCST90502094 | 0.14 |
| 7750 | (R)-3-hydroxybutyrylcarnitine levels | GCST90199930 | 0.14 |
| 7751 | ERBB4/NELL1 ratio | GCST90314691 | 0.14 |
| 7752 | Free cholesterol in large HDL | GCST90497786 | 0.14 |
| 7753 | Renal failure (PheCode 585) | GCST90476118 | 0.14 |
| 7754 | AIFM1 levels | GCST90468268 | 0.14 |
| 7755 | IFIH1 levels | GCST90423689 | 0.14 |
| 7756 | CCL8 levels | GCST90468586 | 0.14 |
| 7757 | DKK3 levels | GCST90468998 | 0.14 |
| 7758 | aseg rh volume Pallidum | GCST90002640 | 0.14 |
| 7759 | NPDC1/PTGDS ratio | GCST90315549 | 0.14 |
| 7760 | Triacylglycerol (54:0) [NL-18:0] levels | GCST90025173 | 0.14 |
| 7761 | COL18A1 levels | GCST90468812 | 0.14 |
| 7762 | S100A4 levels | GCST90470518 | 0.14 |
| 7763 | CASP10/PRTFDC1 ratio | GCST90313627 | 0.14 |
| 7764 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502396 | 0.14 |
| 7765 | CHGA levels | GCST90240699 | 0.14 |
| 7766 | IL18R1 levels | GCST90241607 | 0.14 |
| 7767 | SLC9A3R1 levels | GCST90470665 | 0.14 |
| 7768 | EHD3 levels | GCST90469089 | 0.14 |
| 7769 | T1 CAT volume R TemporalFusiformCortexposteriordivision | GCST90384075 | 0.14 |
| 7770 | SELPLG levels | GCST90012046 | 0.14 |
| 7771 | CRADD/SIRT2 ratio | GCST90314243 | 0.14 |
| 7772 | wg lh intensity-contrast lateralorbitofrontal | GCST90003803 | 0.14 |
| 7773 | Platelet count | GCST004603 | 0.14 |
| 7774 | Alanine transaminase (ALT, minimum, inv-norm transformed) | GCST90475115 | 0.14 |
| 7775 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391 | ECGU000391 | 0.14 |
| 7776 | rfMRI connectivity (ICA100 edge 495) | GCST90005348 | 0.14 |
| 7777 | ROBO2 levels | GCST90470490 | 0.14 |
| 7778 | LEPR levels | GCST90469756 | 0.14 |
| 7779 | EFEMP1/TGFBR3 ratio | GCST90314597 | 0.14 |
| 7780 | EDAR/SERPINB1 ratio | GCST90314586 | 0.14 |
| 7781 | EIF4G1/FKBP5 ratio | GCST90314633 | 0.14 |
| 7782 | DTI TBSS L3 Splenium of corpus callosum | GCST90384528 | 0.14 |
| 7783 | PGLYRP2 levels | GCST90470220 | 0.14 |
| 7784 | VCAM1 levels | GCST90471031 | 0.14 |
| 7785 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499543 | 0.14 |
| 7786 | Degree of unsaturation | GCST90502230 | 0.14 |
| 7787 | Monocyte count | GCST90002341 | 0.14 |
| 7788 | DTI autoptx L1 slf r tract | GCST90385161 | 0.14 |
| 7789 | IL18R1 levels | GCST90469565 | 0.14 |
| 7790 | GCC1 levels | GCST90469315 | 0.14 |
| 7791 | AGRP/CCN1 ratio | GCST90313202 | 0.14 |
| 7792 | PPP1R2 levels | GCST90470304 | 0.14 |
| 7793 | GLOD4 levels | GCST90469359 | 0.14 |
| 7794 | PPP3R1 levels | GCST90470307 | 0.14 |
| 7795 | PTPN6/SNAP23 ratio | GCST90315747 | 0.14 |
| 7796 | PTGES2 levels | GCST90470369 | 0.14 |
| 7797 | Sleep disorders (combined) | FING00001311 | 0.14 |
| 7798 | Acute osteomyelitis (PheCode 710.11) | GCST90476222 | 0.14 |
| 7799 | Caries in Clefts patients | FING00000256 | 0.14 |
| 7800 | RTN4R levels | GCST90470508 | 0.14 |
| 7801 | LZTFL1 levels | GCST90469834 | 0.14 |
| 7802 | COL6A3/SPON2 ratio | GCST90314179 | 0.14 |
| 7803 | DTI TBSS MD Posterior limb of internal capsule L | GCST90384591 | 0.14 |
| 7804 | Docosahexaenoic acid levels | GCST90497252 | 0.14 |
| 7805 | F5 levels | GCST90446466 | 0.13 |
| 7806 | IGFBP4 levels | GCST90469530 | 0.13 |
| 7807 | CLEC10A levels | GCST90468763 | 0.13 |
| 7808 | CRTAM/ICAM3 ratio | GCST90314276 | 0.13 |
| 7809 | GUCA2A levels | GCST90469418 | 0.13 |
| 7810 | SPINK2 levels | GCST90470722 | 0.13 |
| 7811 | aparc-Desikan lh area supramarginal | GCST90003103 | 0.13 |
| 7812 | CSNK1G2 levels | GCST90240608 | 0.13 |
| 7813 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95) | GCST90320658 | 0.13 |
| 7814 | platelet count (mean, inv-norm transformed) | GCST90476299 | 0.13 |
| 7815 | DNM3 levels | GCST90469022 | 0.13 |
| 7816 | SNCG levels | GCST90470695 | 0.13 |
| 7817 | CD27/DLL1 ratio | GCST90313771 | 0.13 |
| 7818 | Multiple system atrophy | GCST90406925 | 0.13 |
| 7819 | Triacylglycerol_51:3_[M+NH4]1+ levels | GCST90060494 | 0.13 |
| 7820 | Neurociticism | GCST006940 | 0.13 |
| 7821 | Other disorders of skin and subcutaneous tissue, not elsewhere classified | FING00001036 | 0.13 |
| 7822 | KLK4 levels | GCST90469704 | 0.13 |
| 7823 | F7/F9 ratio | GCST90314743 | 0.13 |
| 7824 | Disorders of choroid and retina | FING00000438 | 0.13 |
| 7825 | CHIT1 levels | GCST90468744 | 0.13 |
| 7826 | Total lipid levels in small HDL | GCST90092950 | 0.13 |
| 7827 | Microalbumin urine | GCST90278639 | 0.13 |
| 7828 | TXLNA levels | GCST90470989 | 0.13 |
| 7829 | Estimated glomerular filtration rate (creatinine, cystatin c) | GCST90428446 | 0.13 |
| 7830 | REST UKBBICA NODEamps25 0021 | GCST90385504 | 0.13 |
| 7831 | KLK11 levels | GCST90012012 | 0.13 |
| 7832 | APOA levels | UKBB00000040 | 0.13 |
| 7833 | PPIB levels | GCST90470291 | 0.13 |
| 7834 | FCRL3 levels | GCST90469207 | 0.13 |
| 7835 | Volume of right anterior amygdaloid area | GCST90475000 | 0.13 |
| 7836 | Omega-3 fatty acid levels | GCST90502436 | 0.13 |
| 7837 | CD274/EFNA4 ratio | GCST90313768 | 0.13 |
| 7838 | HDL cholesterol | GCST90018736 | 0.13 |
| 7839 | GP1BA/HBEGF ratio | GCST90314956 | 0.13 |
| 7840 | Sphingomyelins levels | GCST90499983 | 0.13 |
| 7841 | NELL2/SEZ6L ratio | GCST90315536 | 0.13 |
| 7842 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502411 | 0.13 |
| 7843 | LSP1/NADK ratio | GCST90315331 | 0.13 |
| 7844 | Phosphatidylcholine diacyl C36:4 levels | GCST90240040 | 0.13 |
| 7845 | NRP1 levels | GCST90470085 | 0.13 |
| 7846 | KLK1 levels | GCST90469702 | 0.13 |
| 7847 | Varicose veins of lower extremity (PheCode 454.1) | GCST90476013 | 0.13 |
| 7848 | LAT levels | GCST90469741 | 0.13 |
| 7849 | CTSF levels | GCST90468912 | 0.13 |
| 7850 | CEBPB levels | GCST90468700 | 0.12 |
| 7851 | IDP dMRI ProbtrackX FA cgc r | GCST90003930 | 0.12 |
| 7852 | PODXL2/SEZ6L ratio | GCST90315702 | 0.12 |
| 7853 | 1-stearoylglycerophosphoethanolamine levels | GCST90243780 | 0.12 |
| 7854 | AmygNuclei lh volume Cortical-nucleus | GCST90002654 | 0.12 |
| 7855 | F2R levels | GCST90469168 | 0.12 |
| 7856 | Myeloid white cell count | GCST004626 | 0.12 |
| 7857 | Plasma taurocholenate sulfate* levels in chronic kidney disease | GCST90266040 | 0.12 |
| 7858 | DKK4/REG1A ratio | GCST90314489 | 0.12 |
| 7859 | Cholesteryl ester levels in small VLDL | GCST90092970 | 0.12 |
| 7860 | CST6 levels | GCST90468896 | 0.12 |
| 7861 | GLB1/GUSB ratio | GCST90314931 | 0.12 |
| 7862 | White blood cell count | GCST90278647 | 0.12 |
| 7863 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 0.12 |
| 7864 | CD2AP/USP8 ratio | GCST90313784 | 0.12 |
| 7865 | FADD/MGLL ratio | GCST90314768 | 0.12 |
| 7866 | MANSC1 levels | GCST90469847 | 0.12 |
| 7867 | MEPE/SOST ratio | GCST90315420 | 0.12 |
| 7868 | PTPRZ1 levels | GCST90470388 | 0.12 |
| 7869 | Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) | GCST90269690 | 0.12 |
| 7870 | CD40LG/GP6 ratio | GCST90313822 | 0.12 |
| 7871 | PTPRF levels | GCST90470381 | 0.12 |
| 7872 | Triglycerides in very large HDL | GCST90500481 | 0.12 |
| 7873 | CRHBP levels | GCST90468860 | 0.12 |
| 7874 | platelet count (minimum, inv-norm transformed) | GCST90476302 | 0.12 |
| 7875 | Phenylalanine levels | GCST90092936 | 0.12 |
| 7876 | wg rh intensity-contrast medialorbitofrontal | GCST90003840 | 0.12 |
| 7877 | Mean corpuscular hemoglobin | GCST90002390 | 0.12 |
| 7878 | T1 FreeSurfer DKT lh precentral thickness | GCST90384246 | 0.12 |
| 7879 | Oranges liking | GCST90094807 | 0.12 |
| 7880 | Triglyceride levels in very large HDL | GCST90093014 | 0.12 |
| 7881 | Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | GCST90266045 | 0.12 |
| 7882 | SFTPA1 levels | GCST90470612 | 0.12 |
| 7883 | EGFL7 levels | GCST90469083 | 0.12 |
| 7884 | OTUD7B levels | GCST90470137 | 0.12 |
| 7885 | RUNX3 levels | GCST90242706 | 0.12 |
| 7886 | HGS levels | GCST90469450 | 0.12 |
| 7887 | Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activity | UKBB00000871 | 0.11 |
| 7888 | Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney disease | GCST90265671 | 0.11 |
| 7889 | DPT levels | GCST90469036 | 0.11 |
| 7890 | FXN levels | GCST90469282 | 0.11 |
| 7891 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428 | ECGU000428 | 0.11 |
| 7892 | SEMA3G levels | GCST90242746 | 0.11 |
| 7893 | Enthesopathies of lower limb, excluding foot | FING00000509 | 0.11 |
| 7894 | Treatment/medication code - quinine | Medications | UKBB00000855 | 0.11 |
| 7895 | EDAR/IPCEF1 ratio | GCST90314578 | 0.11 |
| 7896 | Alanine aminotransferase levels | GCST90025979 | 0.11 |
| 7897 | Redundant prepuce, phimosis and paraphimosis | FING00001246 | 0.11 |
| 7898 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 0.11 |
| 7899 | SERPINI1 levels | GCST90470602 | 0.11 |
| 7900 | EDAR/PRDX5 ratio | GCST90314583 | 0.11 |
| 7901 | NT5C3A levels | GCST90470091 | 0.11 |
| 7902 | NOTCH1/SEMA7A ratio | GCST90315545 | 0.11 |
| 7903 | ROR1/TNFRSF21 ratio | GCST90315787 | 0.11 |
| 7904 | aparc-DKTatlas lh area fusiform | GCST90003239 | 0.11 |
| 7905 | Vegetable intake (standard GWA) | GCST90267306 | 0.11 |
| 7906 | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | GCST90200103 | 0.11 |
| 7907 | Free cholesterol to total lipids ratio in medium HDL | GCST90092897 | 0.11 |
| 7908 | Juvenile arthritis (FINNGEN) | FING00000704 | 0.11 |
| 7909 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | GCST90475282 | 0.11 |
| 7910 | Reticulocyte percentage | Blood count | UKBB00000753 | 0.11 |
| 7911 | Epstein-Barr virus EA-D antibody levels | GCST90006898 | 0.11 |
| 7912 | FGFR4 levels | GCST90469234 | 0.11 |
| 7913 | Omega-6 fatty acids to omega-3 fatty acids ratio | GCST90499199 | 0.11 |
| 7914 | ANXA3/EDAR ratio | GCST90313280 | 0.11 |
| 7915 | Mean volume of bilateral amygdala | GCST90474997 | 0.11 |
| 7916 | TGFBR2/TNFRSF19 ratio | GCST90315917 | 0.11 |
| 7917 | COL2A1 levels | GCST90468816 | 0.11 |
| 7918 | Right-hemisphere visual network to amygdala white-matter structural connectivity | GCST90302786 | 0.11 |
| 7919 | AKT2 levels | GCST90468277 | 0.11 |
| 7920 | wg lh intensity-contrast precentral | GCST90003815 | 0.11 |
| 7921 | Extrapyramidal and movement disorders | FING00000527 | 0.11 |
| 7922 | creatinine (mean, inv-norm transformed) | GCST90475229 | 0.11 |
| 7923 | CD200R1/CLEC4G ratio | GCST90313748 | 0.11 |
| 7924 | Ulcerative colitis (strict) with PSC | FING00001389 | 0.11 |
| 7925 | Addison's disease | GCST90011871 | 0.11 |
| 7926 | SIRPB1 levels | GCST90470640 | 0.11 |
| 7927 | Eye problems/disorders - None of the above | Eyesight | UKBB00000232 | 0.11 |
| 7928 | DIPK2B levels | GCST90468996 | 0.11 |
| 7929 | Eosinophil count | GCST90002299 | 0.11 |
| 7930 | Phospholipids to total lipids in small LDL percentage (UKB data field 23624) | GCST90269721 | 0.11 |
| 7931 | Other benign neoplasms of skin | FING00000971 | 0.11 |
| 7932 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 0.11 |
| 7933 | Principal component-derived dietary pattern 12 | GCST90133017 | 0.11 |
| 7934 | ATG4A/TPMT ratio | GCST90313370 | 0.11 |
| 7935 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2 | ECGA000002 | 0.11 |
| 7936 | CHMP1A/EREG ratio | GCST90314048 | 0.11 |
| 7937 | SCARF2 levels | GCST90470537 | 0.11 |
| 7938 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500472 | 0.11 |
| 7939 | Hair/balding pattern: Pattern 1 (UKB data field 2395_1) | GCST90043616 | 0.11 |
| 7940 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394 | ECGU000394 | 0.11 |
| 7941 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390 | ECGU000390 | 0.11 |
| 7942 | Glycine levels | GCST90497315 | 0.11 |
| 7943 | SFRP1 levels | GCST90470610 | 0.11 |
| 7944 | Phospholipids in large LDL | GCST90498053 | 0.11 |
| 7945 | Blood cell traits latent factor 16 (white cell) | GCST90559258 | 0.11 |
| 7946 | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels | GCST90199858 | 0.11 |
| 7947 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1 | ECGA000001 | 0.11 |
| 7948 | Alanine levels (UKB data field 23460) | GCST90269557 | 0.11 |
| 7949 | PFDN5 levels | GCST90242340 | 0.11 |
| 7950 | Volume of right whole amygdala | GCST90475057 | 0.11 |
| 7951 | Creatinine levels in bottom 99% of individuals by creatinine levels | GCST90566733 | 0.11 |
| 7952 | HBEGF levels | GCST90469433 | 0.11 |
| 7953 | CEACAM8 levels | GCST90468698 | 0.11 |
| 7954 | Left-hemisphere control network to thalamus white-matter structural connectivity | GCST90302752 | 0.11 |
| 7955 | Cholesteryl esters to total lipids ratio in small HDL | GCST90092947 | 0.11 |
| 7956 | wg rh intensity-contrast lateraloccipital | GCST90003837 | 0.10 |
| 7957 | CMC1 levels | GCST90468794 | 0.10 |
| 7958 | IDP dMRI TBSS L1 Sagittal stratum R | GCST90004105 | 0.10 |
| 7959 | potassium (maximum, inv-norm transformed) | GCST90476304 | 0.10 |
| 7960 | X-18601 levels | GCST90243501 | 0.10 |
| 7961 | LCN2 levels | GCST90469747 | 0.10 |
| 7962 | Right ventricular end diastolic volume | GCST90134588 | 0.10 |
| 7963 | Functional dyspepsia | FING00000561 | 0.10 |
| 7964 | FCRL2/TNFRSF13B ratio | GCST90314801 | 0.10 |
| 7965 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392 | ECGU000392 | 0.10 |
| 7966 | Disorders of eyelid, lacrimal system and orbit | FING00000439 | 0.10 |
| 7967 | aparc-DKTatlas lh thickness paracentral | GCST90003555 | 0.10 |
| 7968 | Sum neutrophil eosinophil counts | GCST004613 | 0.10 |
| 7969 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393 | ECGU000393 | 0.10 |
| 7970 | Phospholipids in small LDL | GCST90499681 | 0.10 |
| 7971 | GP1BA levels | GCST90469380 | 0.10 |
| 7972 | Other and unspecified psoriasis | FING00000950 | 0.10 |
| 7973 | BA-exvivo lh thickness BA4p | GCST90003518 | 0.10 |
| 7974 | BACH1/PDLIM7 ratio | GCST90313445 | 0.10 |
| 7975 | MSRA levels | GCST90469951 | 0.10 |
| 7976 | CASP3/CRKL ratio | GCST90313631 | 0.10 |
| 7977 | IL1RN/LGALS9 ratio | GCST90315160 | 0.10 |
| 7978 | BLNK levels | GCST90468448 | 0.10 |
| 7979 | FAM172A levels | GCST90469184 | 0.10 |
| 7980 | aseg lh intensity Accumbens-area | GCST90003774 | 0.10 |
| 7981 | CDSN levels | GCST90468688 | 0.10 |
| 7982 | Docosahexaenoic acid to total fatty acids percentage | GCST90497270 | 0.10 |
| 7983 | Left-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302740 | 0.10 |
| 7984 | APOA1 levels | GCST90468331 | 0.10 |
| 7985 | Blood urea nitrogen levels | GCST90278623 | 0.10 |
| 7986 | DTI autoptx FA ptr l tract | GCST90385131 | 0.10 |
| 7987 | CD244 levels | GCST90468611 | 0.10 |
| 7988 | AK2 levels | GCST90468270 | 0.10 |
| 7989 | Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental health | UKBB00000338 | 0.10 |
| 7990 | ANXA1 levels | GCST90468316 | 0.10 |
| 7991 | Mean corpuscular haemoglobin | Blood count | UKBB00000447 | 0.10 |
| 7992 | IDP dMRI TBSS ISOVF Posterior corona radiata L | GCST90004504 | 0.10 |
| 7993 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 0.10 |
| 7994 | DCTD levels | GCST90468957 | 0.10 |
| 7995 | Goat cheese liking | GCST90094773 | 0.10 |
| 7996 | TMEM106A levels | GCST90470886 | 0.10 |
| 7997 | Influenza and pneumonia | FING00000679 | 0.10 |
| 7998 | Reticulocyte fraction of red cells | GCST90002406 | 0.10 |
| 7999 | aseg global volume CC-Central | GCST90002609 | 0.10 |
| 8000 | CXCL17 levels | GCST90468929 | 0.10 |